Shopping Cart
- Remove All
- Your shopping cart is currently empty
Kea1-97 is a selective disruptor of interaction between thioredoxin and caspase-3 (IC50 = 10 μ M). Kea1-97 destroys the interaction between thioredoxin and caspase 3 and activates caspases without affecting the activity of thioredoxin.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
10 mg | $41 | In Stock | |
25 mg | $86 | In Stock | |
50 mg | $137 | In Stock | |
100 mg | $227 | In Stock | |
200 mg | $335 | In Stock | |
1 mL x 10 mM (in DMSO) | $30 | In Stock |
Description | Kea1-97 is a selective disruptor of interaction between thioredoxin and caspase-3 (IC50 = 10 μ M). Kea1-97 destroys the interaction between thioredoxin and caspase 3 and activates caspases without affecting the activity of thioredoxin. |
Targets&IC50 | Thiordoxine:10μM, Caspase-3:10μM |
In vitro | KEA1-97 (10 μM, 48h) impaired 231MFP cell survival and proliferation and does not affect viability in MCF10A cells. |
In vivo | KEA1–97 treatment (5 mg/kg ip once per day) was initiated 16 days after the initiation of 231MFP tumor xenografts in immune-deficient SCID mice. |
Molecular Weight | 335.16 |
Formula | C15H9Cl2FN4 |
Cas No. | 2138882-71-8 |
Smiles | Fc1ccc(cc1)-c1ccc(Nc2nc(Cl)nc(Cl)n2)cc1 |
Relative Density. | 1.466 g/cm3 (Predicted) |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
Solubility Information | DMSO: 90 mg/mL (268.53 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.